arrow
Е

Е. А. Smolyarchuk

Sechenov University
H指数:17
被引数:4,846

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mechanisms of Resistance to MEK Inhibitors (RAS–MAPK Pathway) in Malignant Peripheral Nerve Sheath Tumors and Their Precursor Lesions (Plexiform Neurofibromas) Associated with Neurofibromatosis Type 1

N1型神经纤维瘤病相关恶性周围神经鞘瘤及其前体病变(丛状神经纤维瘤)对MEK抑制剂(RAS–MAPK通路)的耐药机制

Cancers
IF4.4
2026-09-120
OA
Modern Drug Delivery Platforms Based on Photocrosslinkable Hydrogels (PCHs) in Dentistry: From Material Characteristics to Clinical Applications—A Review

基于光交联水凝胶(PCHs)的现代药物递送平台在牙科中的应用:从材料特性到临床应用——综述

2026-05-300
OA
Antimicrobial, Anti-Inflammatory, General Toxicity and Antioxidant Activities of Ultrasound-Assisted Extracts from Prunella vulgaris L.

超声波辅助提取的夏枯草提取物具有抗菌、抗炎、一般毒性和抗氧化活性

2026-01-010
OA
Comparative Analysis of the Use of Osteoplastic Materials in Socket Augmentation: A Systematic Review

骨塑形材料在拔牙窝增量中的应用比较分析:一项系统评价

2025-10-290
OAAI
Base-Catalyzed Reaction of Isatins and (3-Hydroxyprop-1-yn-1-yl)phosphonates as a Tool for the Synthesis of Spiro-1,3-dioxolane Oxindoles with Anticancer and Anti-Platelet Properties
2024-10-080
OAAI
Unraveling the Mechanism of Platelet Aggregation Suppression by Thioterpenoids: Molecular Docking and In Vivo Antiaggregant Activity
2023-11-270
OAAI
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine Sputnik Light for prevention of coronavirus infection in healthy adults
2021-12-0142
OAAI
Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study

重组亚单位结核疫苗候选物GamTBvac的安全性和免疫原性: 一项II期,多中心,双盲,随机,安慰剂对照研究

2020-11-0344
OAAI